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Abstract
Background: Traction is commonly used for the treatment of low back pain (LBP), predominately
with nerve root involvement; however its benefits remain to be established. The aim of this study
was to test the feasibility of a pragmatic randomized controlled trial to compare the difference
between two treatment protocols (manual therapy, exercise and advice, with or without traction)
in the management of acute/sub acute LBP with 'nerve root' involvement.
Methods: 30 LBP patients with nerve root pain were recruited and randomly assigned to one of
two treatment groups. Primary outcome measures were the: McGill pain questionnaire, Roland
Morris disability questionnaire, and the SF36 Questionnaire; recorded at baseline, discharge, 3 and
6 months post-discharge.
Results: 27 patients completed treatment with a loss of another four patients at follow up.
Intention to treat analysis demonstrated an improvement in all outcomes at follow up points but
there appeared to be little difference between the groups.
Conclusion: This study has shown that a trial recruiting patients with 'nerve root' problems is
feasible. Further research based upon a fully powered trial is required to ascertain if the addition
of traction has any benefit in the management of these patients.
Trial Registration: Registration number: ISRCTN78417198
Background
There is ongoing confusion surrounding the use of trac-
tion in the management of low back pain (LBP), with dif-
ferences between recommendations in the UK, New
Zealand, Denmark and the USA clinical guidelines [1].
This is further confounded by a recent Cochrane system-
atic review which concluded that 'traction probably is not
effective,' however, the authors also noted that 'we lack
strong, consistent evidence regarding the use of traction due to
the lack of high quality studies, the heterogeneity of study pop-
ulations, and lack of power. Any future research should distin-
guish between symptom pattern and duration and should be
carried out according to the highest methodological standard to
avoid bias [2].'
Despite such recommendations, traction continues to be
commonly used by physiotherapists in the management
of LBP; a recent UK-wide survey indicated that 41% of
therapists used traction with 5% of LBP patients, who
almost exclusively presented with 'nerve root' problems
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[3]. Between 3 – 10% of LBP sufferers will experience 'sci-
atica' or 'nerve root' pain, with or without neurological
signs [4-6] with 90% recovering, but a further 10% requir-
ing surgery [6]. Guidelines highlight this small group of
patients in their triage system with the implication that
this group of patients may be more severe, slower to
recover, and may require specialist referral when com-
pared to 'simple' LBP [5,7-10]. Effective management of
this group of patients is therefore essential to limit costly
onward referral and surgery that may result.
This study was designed to assess the feasibility of a prag-
matic randomized controlled trial (RCT) designed to
examine the effectiveness of traction with this subgroup of
LBP, employing treatment parameters indicated by clini-
cal practice and expert opinion [3]. As manual therapy is
often used in conjunction with traction in the manage-
ment of 'nerve root' problems, this study compared the
addition of traction to a manual therapy treatment proto-
col (manual therapy, exercise and advice, with or without
traction).
The specific objectives of this study were to ascertain the
feasibility of the study protocol, in particular the screen-
ing and adequate recruitment of 'nerve root' patients.
Methods
Ethical approval was granted by the Research Ethical
Committee of the University of Ulster. This multicentred,
pragmatic randomized controlled trial was set in three
physiotherapy departments in the Down Lisburn Health
and Social Care Trust, Northern Ireland. General Practi-
tioners in this catchment area were contacted to ensure
early referral to physiotherapy of LBP patients with nerve
root involvement.
Subjects were included if they fulfilled the following 
criteria
(i) Aged 18–65 years of age (male and female), presenting
with acute/sub-acute LBP with accompanying radiculopa-
thy;
(ii) Radiculopathy or 'nerve root' was identified by the
presence of:
Dermatomal pain distribution radiating below the knee
(one or both limbs), of a sharp/severe quality, often worse
in the leg than back (leg pain threshold of 3/10 VAS).
With at least one of the following signs and symptoms:
(a) Pins and needles in the distal dermatome (where this
was present patients with leg pain were accepted even if
not extending below the knee);
(b) Increased pain in the leg on coughing, sneezing or
straining;
(c) Neurological deficit i.e. decreased muscle strength/
sensory loss/reflex loss;
(d) Positive straight leg raise test i.e. limb symptoms
reproduced on SLR test below 90 degrees [5,8,10-12];
(iii) Acute/sub acute LBP, defined as LBP of less than 12
weeks duration [5,7], or a recurrent episode with a pain
free period of at least three months prior to the onset of
this episode. Only one study has considered recovery rates
with 'sciatica' [13] and reported that both back and leg
pain decreased, on average, by 69%, and disability
decreased by 57% within one month from onset. Current
physiotherapy practice would suggest that treatment
begins as soon as possible; therefore patients were
accepted after 4 weeks of onset of leg pain;
(iv) Able to attend for physiotherapy 2–3 times a week for
4–6 weeks;
(v) Patients were literate with English as their first lan-
guage.
Subjects were excluded if they presented with
(i) Previous spinal surgery;
(ii) Formal therapeutic or medical intervention within the
last three months (eg epidural injection, facet joint block,
physiotherapy etc);
(iii) Co-existing conditions (anklyosing spondolytitis,
rheumatoid arthritis, spinal stenosis (diagnosed), spond-
olythesis, recent spinal fracture, spinal tumor or a patient
where secondary metastases was suspected);
(iv) Concomitant severe medical problem preventing par-
ticipation in the trial (cardiac condition, respiratory con-
ditions, neurological disorder or organ disease);
(v) Long term oral steroid intake (due to the risk of oste-
oporosis);
(vi) Current anti-coagulant therapy or blood clotting dis-
orders;
(vii) Pregnancy;
(viii) History of major psychiatric illness;
(ix) Roland Morris disability questionnaire score of below
4, and/or a VAS score of less than 3 on a 10 point scale for
leg pain (to avoid floor effects).BMC Musculoskeletal Disorders 2007, 8:118 http://www.biomedcentral.com/1471-2474/8/118
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Research design
The research design was an investigator-blinded prag-
matic RCT with two active treatment arms.
Two physiotherapists were appointed in each of the three
research sites: these were responsible for the initial screen-
ing of incoming referrals, onward referral of patients to
the research therapist, and treatment of patients entered
into the trial.
The research therapist (who was blind to group alloca-
tion), performed the baseline and outcome measures.
Randomization was performed by an independent
researcher not otherwise involved in the trial through a
pre-determined randomization table [14]; group alloca-
tion was placed in a sealed opaque envelope and num-
bered 1 – 30 for each trial patient. Patients and therapists
were instructed not to reveal to the research therapist the
treatment group to which they had been allocated (Fig 1).
Outcome measures were recorded at baseline, discharge
and again at 3 and 6 months post completion of treat-
ment; the 3 and 6 month follow-up were completed by
post. Primary outcome measures used were: McGill pain
questionnaire (MPQ) [15-17], Roland-Morris disability
questionnaire (RMDQ) [18], Short-form 36 (SF36) [19],
and the Acute LBP screening questionnaire (ALBPSQ)
[20,21]. Secondary outcomes were recorded at each treat-
ment session by the treating physiotherapist: visual ana-
logue scale for back and leg pain (VAS) [22,23] and
percentage of overall improvement as perceived by the
patient [24]. In addition a medication diary was recorded
by the patient throughout treatment, and a general ques-
tionnaire pertaining to recurrence, further treatment etc
was collected at 3 and 6 months.
Treatment Groups
Manual Therapy Group (MT)
Patients randomly assigned to this group received manual
therapy, exercises and advice. In the absence of any spe-
cific treatment protocol for the management of 'nerve
root' this represented the "best treatment for acute LBP" as
designated by the Clinical Standards Advisory Group [7]
and the Royal College General Practitioners Guidelines
[8]. Treating physiotherapists were limited to using the
techniques contained within the protocol, but were free to
choose the selection of techniques considered most
appropriate for that patient at any point during treatment.
Manual therapy: was defined as any mobilization and/or
manipulation techniques for the spine described by Mait-
land [25] or Cyriax [26]. The physiotherapist had freedom
of choice of which to use and when, and the spinal regions
to which they were applied.
Exercises included specific exercises and/or advice to stay
active; the former included any exercises that the therapist
felt was appropriate for an individual patient e.g. mobiliz-
ing exercises, abdominal and back strengthening exer-
cises, extension exercises or core stability.
Advice: to stay active included continuing with activities or
introducing activity e.g. the addition of short walks, swim-
ming or continuing with reduced activities of daily living;
gentle mobilizing or strengthening exercises could also be
included. Relevant advice was also given to the patient e.g.
sleeping positions, sitting positions, education re progno-
sis and recurrence rates etc. The "Back Book" [27], an evi-
dence-based patient education booklet, was given to all
patients by the treating therapist to reinforce the informa-
tion verbally given to the patient.
Traction group (LT)
This arm of the trial was based upon the same interven-
tion as the manual therapy group but with the addition of
motorized (static) lumbar traction. Lumbar traction was
used initially with these patients but the therapist could
also select to use mobilization techniques in conjunction
with traction, or to exchange traction for mobilization
techniques as the patient improved (therapist's clinical
judgment). The parameters for traction application were
established from expert opinion and from the results of a
UK wide survey (Table 1).
Excluded treatments
Patients were not permitted to receive any other types of
manual therapy (e.g. Mulligan, McKenzie regimes), elec-
trotherapy, or any additional interventions (acupuncture,
taping, corset, heel raises) during the intervention period
of the trial. These were excluded as the UK wide survey [3]
informing this trial had not indicated a common use of
these modalities in conjunction with traction.
Statistical analysis
All data were scored and entered onto the Statistical Pack-
age for the Social Sciences (version 11) for analysis. Due
to the small sample size and the chance of Type 2 error,
inferential statistics were not used in the analyses; instead
descriptive statistics were employed to compare the data
between the two groups (median and interquartile range,
as data were skewed). Intention to treat analysis was per-
formed. The imputation method used to replace missing
data for all study participants who failed to complete
treatment or follow up was the last available score forward
method; an alternative per protocol was also performed
for those that completed treatment and follow up. SF36
was analysed as norm-based data and presented as com-
ponent scores for physical and mental components.
Appropriate descriptive statistics are presented for base-
line characteristics (Table 2).BMC Musculoskeletal Disorders 2007, 8:118 http://www.biomedcentral.com/1471-2474/8/118
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Clinical trial procedure Figure 1
Clinical trial procedure.
Patient referred to 
physiotherapy 
departments DLT via 
GP 
Referrals screened by research therapists 
(appointed within each trust), potential trial 
patients identified and passed to principle 
researcher
Patient screened via telephone interview by 
principle researcher. On meeting inclusion 
criteria and expressing a willingness to 
participate they will be invited to attend for 
further assessment for inclusion in the 
study 
I
st attendance: Inclusion criteria confirmed, written 
consent obtained, outcome measures completed. 
Randomized (concealed) and begin treatment on 
the same day 
Manipulative group (MT)  
• Mobilizations 
• Exercise 
• Back Book 
Traction group (LT) 
• Traction 
• Mobilizations 
• Exercises
• Back Book
Outcome measures
• RMDQ, MPQ-PRI, and 
      SF36 at baseline,   
      discharge, 3 & 6 months. 
• ACLBPSQ baseline 
assessment only 
• VAS, % improvement, 
neurological and SLR 
changes recoded at 
baseline & each treatment 
session 
• Medication diary 
• Questionnaire – 
recurrence and treatment 
at 3 & 6 months.
Patients not fulfilling the 
criteria or who do not 
want to participate will be 
returned to routine care. 
Patients fulfilling DLT 
urgent criteria will be 
given an appointment 
with another therapist
Discharge  
• When therapist deems 
it appropriate from a 
clinical perspective. 
• When no further 
improvement -VAS, or 
% improvement is 
unchanged for 4 
consecutive 
treatments. 
• Patient fails to attend 
three consecutive 
appointments BMC Musculoskeletal Disorders 2007, 8:118 http://www.biomedcentral.com/1471-2474/8/118
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Results
A total of 101 patients were screened; 30 patients entered
the trial between March 2004 and February 2005 (Figure
2 CONSORT flow diagram shows the progression through
the trial).
Compliance with treatment and follow up
All patients received the treatment to which they were
allocated; 27 patients completed treatment, 3 patients
failed to complete treatment, one patient was lost to fol-
low up at 3 months and a further three patients at 6
months (Fig 2). Subjects in each group received a similar
number of treatments (LT, mean 11.4, SD 5; MT mean 10,
SD 3.3) lasting no longer than 30 min at each session and
were seen for treatment on an average of twice weekly
(Mean LT 2.3, SD .79; MT 2; SD .73), ensuring equal con-
tact time for each group.
Patient demographics
The mean age of patients in the study was 44.1 years (SD
10 years; range 29 – 60 years); 40% (n = 12) were male
and 60% (n = 18) were female (Table 2). The mean dura-
tion of the current episode of LBP was 7 weeks (SD 2.7
weeks; range 4 – 12 weeks).
The baseline demographics, clinical characteristics, and
outcome measure scores showed some differences
between groups; most notably was that the MT group had
a higher proportion off work due to LBP, a greater history
of episodes of LBP, they participated less in physical activ-
ity and they also had more neurological signs than the LT
group. These findings are possibly reflected in the higher
median scores for several of the outcome measures and
may have an impact on the results of this study (Table 2).
Outcomes
Fig 3, 4, 5, 6 shows the median points for the main out-
comes plotted graphically. These results demonstrate a
trend of improvement in both groups at follow up points
but there appears to be little difference between the two
groups. In comparing the data for those subjects who
'completed' the trial (per protocol) a similar trend was
noted with little effect due to the intention to treat analy-
sis (Table 3). Change scores between baseline and the
three follow up points demonstrate a similar trend (Table
4).
Percentage of overall improvement (as perceived by the
patient) at completion of treatment was similar for both
groups: LT group median score 90% (IQR 24); MT group
90% (IQR 22.5). Follow up questionnaire at 3 and 6
months showed similar results for both groups (Addi-
tional file 1). At the 3 month follow up several patients
had sought further treatment: GP (19.2%, n = 5), Ortho-
paedic Consultant (7.7%, n = 2) and Chiropractor (3.8%,
n = 1). One patient had had surgery (discectomy) and two
patients were awaiting MRI. At the 6 month follow up two
patients were waiting to see an orthopaedic consultant,
but despite only small improvements in pain and disabil-
ity no other treatments were sought.
Discussion
Recruitment of 'nerve root' patients can be difficult as it
has been reported that only 3 – 10% of LBP suffers have
these symptoms [4-6]. However this study has demon-
strated that a clinical trial with this sub-group of LBP
patients is feasible. Recruitment was slow and occurred
over an 11 month period with 101 patients screened by
telephone to achieve the target of 30 patients for this trial.
A larger trial would require a multi-centered design to suc-
cessfully recruit the numbers required for a fully powered
study. The initial telephone screening procedure imple-
mented in this trial was appropriate, and only one patient
required attendance for further screening before a desci-
sion could be made; furthermore only one patient refused
consent to participate in the trial. Although specific data
was not retained on those excluded from the trial, the
most common reasons were that they did not meet the
'nerve root' criteria or the time from onset of 4–12 weeks.
This screening process ensured recruitment of patients
with predominantly L4/5 and L5/S1 nerve root symp-
toms; this is cited as being the most commonly affected
nerve root, and thus this group was considered represent-
ative [5,28]. This method facilitated the screening of a
large number of patients within a minimal timeframe,
and would be appropriate for a large multi centre trial.
The results of this study demonstrated an improvement in
both groups throughout the trial but with little difference
demonstrated between the groups, however this is to be
expected in a group of this size. Improvement however
cannot be attributed to the intervention as natural
improvement can not be discounted as a non-interven-
tion control was not used in this trial. Additionally, while
there were differences in baseline characteristics between
groups which may have confounded the results a larger
randomised trial would overcome this. Analysis was com-
pleted through the intention to treat principle (last avail-
Table 1: Traction parameters: nerve root patients
Traction parameter Recommended guidelines (Harte et al 2005)
Traction bed Split table motorized traction unit
Traction Position Fowler position (hips and knees flexed to 90 
supported on stool
Traction Weight 5 – 60 kg
Traction duration 10 – 20 min each session
Traction Frequency 2 – 3 times per weekBMC Musculoskeletal Disorders 2007, 8:118 http://www.biomedcentral.com/1471-2474/8/118
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Table 2: Baseline demographics for both groups
LT group (n = 16 MT group (n = 14)
Age (Mean, SD) 45.25 (7.99) 42.79 (12.09)
Gender (%, N)
Male 37.5 (6) 42.9 (6)
Female 62.5 (10) 57.1 (8)
Employment (%, N)
In paid employment 68.8 (11) 78.6 (11)
Not in paid employment 31.5 (5) 21.4 (3)
Job description (%, N)
Heavy manual work 25 (4) 35.7 (5)
Light work – desk/supervisory 31.3 (5) 28.6 (4)
Homemaker 1.8 (3) 21.4 (3)
Professional 12.5 (2) 7.1 (1)
Retired 6.3 (1) 7.1 (1)
Incapacity benefit 6.3 (1) 0
Sick leave from work (%, N)
Not applicable 31.5 (5) 14.3 (2)
At work 43.8 (7) 42.9 (6)
Off work due to LBP 25 (4) 42.9 (6)
Weeks duration of LBP (Median, IQR) 6.5 (4.8) 6 (4)
Number of episodes of LBP in the past year (%, N)
None 81.3 (13 42.9 (6)
1–3 6.3 (1) 42.9 (6)
Constant LBP 12.5 (2) 14.3 (2)
Number of months since last episode of LBP (%, N)
No episodes 81.3 (13) 35.7 (5)
3–6 months 03 5 . 7  ( 5 )
7–12 months 6.3 (1) 7.1 (1)
>1 year 0 7.1 (1)
Constant LBP 12.5 (2) 14.3 (2)
Previous treatment for LBP (%, N)
Yes 12.5 (2) 14.3 (2)
No 50 (8) 50 (8)
Not applicable 37.5 (6) 28.6 (4)
Participation in physical activity (%, N) 62.5 (10) 35.7 (5)
Continued with activity since onset of this episode (%, N) 18.6 (3) 21.4 (3)
Smoker (%, N)
Current smoker 25 (4) 28.6 (4)
Past smoker 6.3 (1) 21.4 (3)
None smoker 68.8 (11) 50 (7)
Neurological/Neurodynamic changes (%, N)
Reflex – reduced/absent 18.8 (3) 35.7 (5)
Muscle power – reduced/absent 37.5 (6) 50 (7)
Sensation – decreased/hypersensitive 18.8 (3) 28.6 (4)
SLR – restricted and reproducing leg pain 100 (16) 78.6 (11)
Crossed SLR 6.3 (1) 21.4 (3)BMC Musculoskeletal Disorders 2007, 8:118 http://www.biomedcentral.com/1471-2474/8/118
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able score forward method), however on analysis per
protocol the results demonstrated similar trends.
As this was a feasibility study with a small sample size and
limited statistical power, it may not detect beneficial
effects or important relationships between variables there-
fore a sample size calculation was conducted based on the
minimum clinical difference of the RMDQ of 2 points
[28]. This indicated 50 subjects would be required for
each intervention group (90% power, alpha value of 0.05)
and allowing for 15% attrition at three follow-up points a
sample size of 76 subjects per group would be required for
a larger study [14,29]. This would be achievable in a
multi-centered design.
This study was designed to investigate the feasibility of a
trial of traction with a clearly defined subgroup of LBP
patients, who had previously been identified as the group
most likely to receive traction in routine clinical practice
[3]. The presence of clinically diverse subgroups of LBP
patients may confound broadly based research trials in
this area, as particular treatments may only be effective
with distinct subgroups of subjects. 'Nerve root' is perhaps
the most easily identified and arguably the least disputed
subgroup. This study advances previous work on traction
with LBP patients with 'nerve root' symptoms in the
acute/sub acute phase. A number of previous RCTs have
examined the effectiveness of lumbar traction with this
group of patients; however many of these failed to define
'nerve root' adequately [30-33], and many have included
patients outside the acute/sub acute phase [30,31,33-37].
Only two previous studies adequately defined nerve root
involvement and included patients in the acute/sub acute
phase [38,39]: both of these were rated as low quality
studies [40]: one with positive [38], and one with negative
results [39]. However the Larsson [38] study did not
employ clinically appropriate treatment parameters,
which is an important issue as it can lead to serious per-
formance bias in a trial [40-42]. The current study has
attempted to address these issues, by establishing treat-
ment parameters from expert and clinical opinion [3,40],
but it is not possible to state that these are the 'best' treat-
ment parameters available as treatment doses are difficult
to establish. However these parameters are important in
that they are currently being used by those therapists who
feel it is an effective treatment for this subgroup and in the
absence of 'best' treatment doses it is a reasonable starting
point.
Another possible limitation in the design of previous trac-
tion studies has been the use of traction in isolation, as
physiotherapists and other clinicians tend to work using a
polytherapy approach [3,24,43-46]. Physical therapy is
characterised by diverse combinations of treatments
which often move from passive towards a more active
Consort flow diagram Figure 2
Consort flow diagram.
 
Excluded (n = 71) 
  Not meeting 
  inclusion criteria (n = 70)
  Refused to participate 
  (n = 1) 
Randomized (n = 30) 
Allocated to LT group 
intervention (n =16) 
   Received allocated    
    Intervention (n = 16)
Allocated to MT group      
intervention (n = 14) 
   Received allocated    
    Intervention (n = 14)
Lost to follow up:  
• Post treatment (n = 14), 
2 failed to complete 
treatment 
• 3 month (n = 14) 
• 6 month (n =13) 
1 failed to return 
outcomes 
Lost to follow up: 
• Post treatment (n = 
13),  1failed to 
complete treatment 
• 3 month (n = 12), 1 
failed to return 
outcomes 
• 6 month (n = 10), 2 
failed to return 
outcomes
Completers (n = 13) 
   
Completers (n = 10) 
Assessed for 
eligibility (n = 101) 
Outcome measures (Median, IQR)
RMDQ 10 (4.5) 11.5 (8.5)
MPQ-PRI 20.5 (9) 29 (20)
ALBPSQ 104 (42.5) 112 (49)
SF36 Physical component score (PCS) 31 (3.6) 36.1 (23.4)
SF36 Mental component score (MCS) 46.5 (17.2) 47.3 (21.3)
VAS back pain 5 (4.5) 5 (4.5)
VAS leg pain 7 (3.5) 5.6 (3.5)
Table 2: Baseline demographics for both groups (Continued)BMC Musculoskeletal Disorders 2007, 8:118 http://www.biomedcentral.com/1471-2474/8/118
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Median score for RMDQ at follow up points Figure 3
Median score for RMDQ at follow up points.
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Median score for MPQ – PRI at follow up points Figure 4
Median score for MPQ – PRI at follow up points.
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Median score for SF36 physical component score at follow up points Figure 5
Median score for SF36 physical component score at follow up points.
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Median score for SF36 mental component score at follow up points Figure 6
Median score for SF36 mental component score at follow up points.
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form of treatment in the latter stages of a management
programme [43,46]. Indeed therapists in this study
tended to use a combination of all the components of the
treatment protocol i.e. manual therapy and/or traction,
advice and exercise combined in many different ways
throughout the treatment program to reflect the needs of
their patients. Delitto (2005) has suggested that we have
been looking for the 'magic bullet' for LBP management,
with explanatory trials subjecting all non-specific LBP
patients to the same treatments; he has argued that this
will not provide the answers we seek. Instead studies
should be planned that reflect the clinical environment
[47]. The pragmatic randomised trial design used in the
current study allowed the therapists the flexibility of treat-
ing patients individually using a polytherapy approach,
based upon clinical reasoning, within a wider research
protocol. This design allowed investigation of the effects
Table 3: Outcome scores at baseline, post treatment, 3 and 6 months follow up for completers and intention to treat analysis
Per protocol analysis Intention to treat analysis
LT Group (n = 13) Median (IQR) MT Group (n = 10) Median (IQR) LT Group (n = 16) Median (IQR) MT Group (n = 14) Median (IQR)
RMDQ baseline 10 (4.5) 11.5 (8.5) 10 (4.5) 11.5 (8.5)
after 4 (3) 1.5 (9.5) 4 (5.8) 4 (10.3)
3 months 2 (8.5) 1 (11.3) 4.5 (10.8) 1 (10.5)
6 months 4 (9.5) 1.5 (6.8) 4.5 (15.3) 2.5 (14)
MPQ-PRI baseline 20.5 (9) 29 (20) 20.5 (9) 29 (20)
after 2 (7.5) 9 (16.3) 4 (15.3) 12 (16.5)
3 months 4 (11) 1 (23) 6 (16.5) 6 (21)
6 months 5 (16.5) 3 (20.3) 10 (20.5) 6.5 (21)
SF36 PCS baseline 31 (3.6) 36.1 (23.4) 31 (3.6) 36.1 (23.4)
after 43.9 (13.4) 46.2 (24.1) 38.5 (16.2) 41.1 (21.1)
3 months 46.3 (17.9) 45.9 (27.4) 41.6 (18.6) 43.2 (24)
6 months 42.7 (16.7) 50.5 (23) 40 (15) 46 (22)
SF36 MCS baseline 46.5 (17.2) 41.2 (25.8) 46.5 (17.2) 41.2 (25.8)
after 53.2 (19.3) 50.4 (27) 52 (26.1) 48.3 (25.6)
3 months 55.2 (24.2) 49.5 (27.7) 49.5 (25.8) 47.3 (21.3)
6 months 52.6 (18.4) 55 (15) 51.8 (23) 49.8 (19.8)
Median score for SF36 mental component score at follow up points Figure 6
Median score for SF36 mental component score at follow up points.
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of a clinically relevant multi-modal approach to back
pain.
Conclusion
This study has shown that a high quality trial with patients
with lumbo-sacral 'nerve root' involvement is possible.
The trial design has addressed important issues: recruit-
ment of a homogenous subgroup of patients (acute/sub
acute stage of nerve root irritation/compression), as well
as the use of clinically appropriate treatment parameters
(treatment length, frequency and weights). The lack of a
clear tend in the data is perhaps not unexpected in an
underpowered study and further research is required with
a fully powered study to ascertain if there is an effect with
the addition of traction to the treatment protocol of mobi-
lisations, advice and exercise. The introduction of a con-
trol group receiving advice and medication (as the
majority of the patients were on medication) would fur-
ther confirm the effects or non-effects of these interven-
tions on patients with LBP and 'nerve root symptoms'.
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